Ryan J Selhorn insider trades
Open-market stock purchases and sales by Ryan J Selhorn, Chief Financial Officer at Aytu Biopharma, Inc, from SEC Form 4 filings since Nov 11, 2024.
Companies traded
- AYTU Aytu Biopharma, Inc: other filings, last Oct 3, 2025